After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked ...

Research led by Memorial Sloan Kettering Cancer Center (MSK) is shedding new light on how ovarian cancer evolves—insights ...

While ovarian cancer is known as the 'silent killer' due to its vague symptoms, it's essential to be aware of the signs - ...

In A Nutshell High-throughput drug screening identified rigosertib as highly selective for ovarian cancer cells. Alone, ...

Ovarian cancer is the third most common cancer among women in India and is often referred to as a ’silent killer’ due to its ...

Research led by Memorial Sloan Kettering Cancer Center (MSK) is shedding new light on how ovarian cancer evolves - insights ...

An unusual DNA structure may hold the key to treating one of the deadliest cancers affecting women, which claims more than ...

Dr. Claire Thompson, a Consultant Gynaecological Oncologist, explains the causes of ovarian cancer and the genetic link that ...

Ovarian cancer is an incredibly deadly and common form of the disease, with approximately 7,500 new cases of ovarian cancer ...

Patients with stage IV ovarian cancer can derive long-term benefits from neoadjuvant pembrolizumab and chemotherapy if they achieve a major pathologic response, according to research published in ...

A new FDA application for relacorilant shows promising survival benefits in treating platinum-resistant ovarian cancer, ...